Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment.
about
Tissue distribution and efficacy of gold nanorods coupled with laser induced photoplasmonic therapy in ehrlich carcinoma solid tumor modelEnhanced efficacy of combination heat shock targeted polymer therapeutics with high intensity focused ultrasound.Guided Delivery of Polymer Therapeutics Using Plasmonic Photothermal Therapy.RGD-conjugated gold nanorods induce radiosensitization in melanoma cancer cells by downregulating α(v)β₃ expressionComparative effect of gold nanorods and nanocages for prostate tumor hyperthermia.Plasmonic photothermal therapy increases the tumor mass penetration of HPMA copolymers.An ultra pH-sensitive and aptamer-equipped nanoscale drug-delivery system for selective killing of tumor cells'Living' PEGylation on gold nanoparticles to optimize cancer cell uptake by controlling targeting ligand and charge densities.Gold nanoparticles in theranostic oncology: current state-of-the-art.Experimental aspects of colloidal interactions in mixed systems of liposome and inorganic nanoparticle and their applications.Nanometric gold in cancer nanotechnology: current status and future prospect.Tumor Targeting via Integrin Ligands.RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.Hyperthermia approaches for enhanced delivery of nanomedicines to solid tumors.RGDfK-functionalized gold nanorods bind only to activated platelets.Micro-CT Imaging of RGD-Conjugated Gold Nanorods Targeting TumorIn Vivo
P2860
Q27304804-9E508C06-BE56-4781-90A2-5CEB0C94B12BQ31146684-52E3F5F3-C25B-41B7-87E6-221CAFFB9E23Q34318312-23C0D119-AF89-472D-B3CB-A334E93CB7F2Q35821081-5755954E-EFFD-438A-B886-9E1B617B3367Q35829879-58789BB0-4841-4E46-9588-32189E658E1AQ37024023-C4AAFDF6-9613-4D1C-A105-0E2D1AADD225Q37239461-DC3CB38A-E52B-450C-B83F-3DBCFFB79C67Q37319230-DE50554E-E9BB-4565-8CA2-BDCD0EA68669Q38035034-09F243F8-9345-4344-84B9-F4988ED25D7CQ38056495-B4ED9451-2D6B-46CE-886D-938DFE3DCEE4Q38100196-49445CD2-52A6-4FDE-9580-BF27FDC69F19Q38134759-11FE19EB-F843-4BC2-8BAF-DC5F83C2231CQ38161395-B55C329A-55BB-403C-BDDA-A375504B16E9Q38494691-C20B4C5A-2C81-400F-B76E-ED6D8B2B909CQ39371541-CC91161A-B283-4E71-8914-A3E293758472Q59128723-EBA21382-D82B-420B-BF22-18739A4DE830
P2860
Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment.
@en
Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment.
@nl
type
label
Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment.
@en
Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment.
@nl
prefLabel
Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment.
@en
Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment.
@nl
P2093
P2860
P1476
Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment.
@en
P2093
Abhijit Ray
Adam J Gormley
Alexander Malugin
Hamidreza Ghandehari
Ryan Robinson
P2860
P304
P356
10.3109/1061186X.2011.623701
P577
2011-12-01T00:00:00Z